Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 125

Patient Safety Monitoring in International Laboratories (SMILE)

Quality Management in
Hematology Laboratory.
By Heidi Hanes

1
Patient Safety Monitoring in International Laboratories (SMILE)

Objectives
• At the end of this presentation should be able to:
Recognize the four components of Quality
Assurance.
Recognize how to troubleshoot problems.
Develop own policy for all aspect of quality
assurance.
Understand what is necessary to undertake a
program of Quality Management in Hematology
Laboratory.

3
Patient Safety Monitoring in International Laboratories (SMILE)

Quality Management includes


• Standardization
• Pre Analytical Control
• Post Analytical Control
• Analytical Control
Internal Quality Control
External Quality Assessment
4
Patient Safety Monitoring in International Laboratories (SMILE)

5
Patient Safety Monitoring in International Laboratories (SMILE)

Standardization
• Collaboration between groups.

• Standard Operating Procedures

• Problem solving for unsatisfactory


performance

• Test selection
6
PRE-ANALYTICAL
CONTROL

7
Patient Safety Monitoring in International Laboratories (SMILE)

Understanding functionality of
your instrument:
• principles of operation
• startup or daily checks
• shutdown procedure
• normal sights and sounds of the
instrument
• familiarize staff to troubleshooting
manual
8
Patient Safety Monitoring in International Laboratories (SMILE)

Hematology Subsystems
• Consist of 3 subsystems.
 Electronic
 Fluidic
 Pneumatics (pressure and vacuums)
 Hydraulics (liquids)
 Reagent

9
Patient Safety Monitoring in International Laboratories (SMILE)

Proper Specimen Collection


• Analyze only specimens that were
properly collected and stored.
Correct Tube
Correct amount of specimen in tube
Proper mixing
Cleanliness of puncture area
Storage

10
Patient Safety Monitoring in International Laboratories (SMILE)

Exercise 1

11
Patient Safety Monitoring in International Laboratories (SMILE)

Pre-Analytical Example 1
21-May-2015
13:45

WBC 0.05 x 10^3/L PASS

RBC 0.00 x 10^6/L PASS

Hgb 0.00 x g/dl PASS

Plt 10.0 x 10^3/U FAILED

12
Patient Safety Monitoring in International Laboratories (SMILE)

Repeat Background
21-May-2015
14:00

WBC 0.05 x 10^3/L PASS

RBC 0.00 x 10^6/L PASS

Hgb 0.00 x g/dl PASS

Plt 15.0 x 10^3/U FAILED

13
Patient Safety Monitoring in International Laboratories (SMILE)

Corrective Action

• Check when reagent(s) last changed.


• Change the most recently added
reagent.
• If none recently added change the
diluent.
• Rerun start-up
14
Patient Safety Monitoring in International Laboratories (SMILE)

Repeat Background
21-May-2015
14:30
WBC 0.05 x 10^3/L PASS

RBC 0.00 x 10^6/L PASS

Hgb 0.00 x g/dl PASS

Plt 2.0 x 10^3/U PASS

15
Patient Safety Monitoring in International Laboratories (SMILE)

Causes for high background

• The uptake tubing got contaminated.


• Reagent agitated before connecting
to instrument.
• Dried reagent spills or leaks.

16
Patient Safety Monitoring in International Laboratories (SMILE)

Copy from Coulter LH780 Manual


17
Patient Safety Monitoring in International Laboratories (SMILE)

Pre-Analytical Example 2
All parameters have a “P” code
Partial Aspiration

18
Patient Safety Monitoring in International Laboratories (SMILE)

What can give this code?

• Sample could be clotted.


• Hemoglobin is less than 4 g/dl
• Sample volume too low.
• The blood detector was turned off.
• Check your instrument manual.

19
Patient Safety Monitoring in International Laboratories (SMILE)

Other Corrective Steps

• Troubleshoot for leaks, kinks or plugs


along the sample flow path.
• Ensure the aspiration lines are clean.
• Check for needle plugs.
• Call Service Hot Line

20
Patient Safety Monitoring in International Laboratories (SMILE)

Pre-Analytical Example 3

Get a 30psi Pressure High Error

21
Patient Safety Monitoring in International Laboratories (SMILE)

Solutions
• Find the 30psi regulator and adjust to 30
+/-0.2 psi.
• Rerun several bloods and compare to see
if any difference.
• If unable to adjust or error occurs again
call Technical Hot line.

22
Patient Safety Monitoring in International Laboratories (SMILE)

23
Post-Analytical Control

Understanding your
instrument results:

24
Flags
• Can be a letter or symbol that appears to
right of the result.
Manufacturer controlled
Aspiration, Linearity, interference
Laboratory controlled
Critical range
Decision rules

25
26
Codes
• Symbols that appear in place of results
Indicate beyond reportable range +++++
Vote-out of aperture
Unable to calculate result
Clogged flow cell

27
Patient Safety Monitoring in International Laboratories (SMILE)

Messages
• Usually manufacturer messages
• Indicate possible abnormal cells,
clumping, agglutination
• Used to decide on reporting of instrument
vs manual differential or verification of
measured results.

28
Patient Safety Monitoring in International Laboratories (SMILE)

I
W

29
Patient Safety Monitoring in International Laboratories (SMILE)

Patient Results
• Are the results consistent with the
patient’s condition?
• Delta checks
Can be set on instrument or LIS.
Checks against previous result.
Value set by laboratory.

30
H & H Check/Difference

• Hgb x 3 = HCT +/- 3%


• If > +/-3 can indicate a problem.
Instrument
Sample

31
Patient Safety Monitoring in International Laboratories (SMILE)

Exercise 2

32
Patient Safety Monitoring in International Laboratories (SMILE)

Post Analytical Example 1


Laboratory Results Instrument Differential
WBC - 8,900/uL Neutrophil % - 52.5%
RBC - 4,460,000/uL Lymphocyte % - 35.2%
Hgb -13.4 g/dl Monocyte % - 10.4%
HCT- 40.7% Eosinophil % - 1.4%
Platelets - 56,000/ul Basophil % - 0.5%
MCV - 91.1.1fl Flags
MCH - 29.9pg WBC interference (*)
MCHC - 32.8g/dl Micro/Fragmented RBC
Giant Platelets
RDW - 23.1%
R (Review)-code on
Platelets
Platelet Clumps

33
Patient Safety Monitoring in International Laboratories (SMILE)

34
Patient Safety Monitoring in International Laboratories (SMILE)

35
Patient Safety Monitoring in International Laboratories (SMILE)

Post Analytical Example 2


Laboratory Results
WBC - 8,500/uL Instrument Differential
RBC - 4,870,000/uL Neutrophil% - 60.9%
Hgb - 16.4 g/dl Lymphocyte % - 28.7%
HCT - 43.5% Monocyte % - 8.2%
Platelets - 356,000/ul Eosinophil% - 2.0%
MCV - 89.5 fl Basophil% - 0.2%
MCH - 23.6 pg Flags
H-H difference check
MCHC - 37.7 g/dl
 Alert (aH) on the MCHC
RDW -12.5%
Spun HCT – 44%

36
Patient Safety Monitoring in International Laboratories (SMILE)

What is the Explanation ?


Spun Plasma
• The MCHC is > 36
• The spun hematocrit matches the
instrument
• It would appear that the Hgb is
incorrect
• Lipemia will falsely increase the
hemoglobin result
• Follow laboratory policy for lipemic
samples

37
Patient Safety Monitoring in International Laboratories (SMILE)

Post Analytical Example 3


Laboratory Result 1 Laboratory Result 2
WBC - 8,500/uL WBC – 8,300/uL
RBC - 4,870,000/uL RBC – 4,000,000/uL
Hgb - 16.4 g/dl Hgb – 16.2 g/dl
HCT – 48.2% HCT – 36.0%
Platelets - 356,000/ul Platelets – 340,000/uL
MCV - 89.5 fl MCV – 90.0 fl
MCH - 33.7 pg MCH – 40.5 pg
MCHC – 34.0 g/dl MCHC – 45.0 g/dl
No flags H-H difference check
Delta Check on HCT
and MCHC

38
Patient Safety Monitoring in International Laboratories (SMILE)

39
Patient Safety Monitoring in International Laboratories (SMILE)

Post Analytical Example 4


Laboratory Result 1 Laboratory Result 2
WBC – 6,300/uL WBC – 6,800/uL
RBC – 2,321,000/uL RBC –3,475,000 /uL
Hgb – 6.5 g/dl Hgb – 9.5 g/dl
HCT – 19.5% HCT – 28.5%
Platelets - 250,000/ul Platelets – 240,000/uL
MCV - 75 fl MCV – 82 fl
MCH – 28.0 pg MCH – 29.0pg
MCHC – 33.3.0 g/dl MCHC – 34.3.0 g/dl
RDW – 9.8 RDW – 13.4
Delta Check on Hgb,
HCT, and MCV

40
Patient Safety Monitoring in International Laboratories (SMILE)

41
Patient Safety Monitoring in International Laboratories (SMILE)

42
Patient Safety Monitoring in International Laboratories (SMILE)

43
Patient Safety Monitoring in International Laboratories (SMILE)

Analytical Control

• Internal Quality Control


• External Quality Assessment

44
Patient Safety Monitoring in International Laboratories (SMILE)

INTERNAL QUALITY
CONTROL

45
Patient Safety Monitoring in International Laboratories (SMILE)

Internal Quality Control includes

• Daily control specimen


Commercial Control
Patient Control
• XB Analysis – Moving Average
• Correlation/Comparison System
• Policy- QC and Troubleshooting

46
Patient Safety Monitoring in International Laboratories (SMILE)

Internal Quality Control

Commercial Controls

47
Patient Safety Monitoring in International Laboratories (SMILE)

Commercial Controls

• Assayed vs Non-assayed

• Introducing New QC Lot

• Establishing QC Ranges

48
Patient Safety Monitoring in International Laboratories (SMILE)

Lot–To-Lot Correlations
1. Set up new QC files for each control level of the new lot.
2. Verify the new lot by running each level of control three times
in its respective file.
3. Ensure that the mean values of the control runs fall within the
ranges published on the manufacturer assay.
4. Run each level twice a day for 3-5 days to calculate new
mean values for each analyte.
5. Compare the calculated mean values for each level to the
range specified on the manufacturer assay sheet.
6. If the calculated mean is within range, enter it as the
expected mean.

49
Patient Safety Monitoring in International Laboratories (SMILE)

Establishing Means and


Standard Deviations
1. Analyze the control(s) a minimum of 20 times across several
days.
2. Take the average of these runs.
3. The average should be within the range state on the assay
sheet.
4. Calculate a two Standard Deviation range from your results.
5. Incorporate this SD range around your new mean and
monitor.
6. The mean and SD values should be periodically recalculated
during the life of the new lot.

50
Patient Safety Monitoring in International Laboratories (SMILE)

Factors to Consider for Means


• Some hematology parameters, such as MCV,
Platelets and RBC will start to change over
time.
• MCV will increase.
• RBC values can decrease.
• Platelets values will increase.
• Mean, SD, and CV should be evaluated
monthly.

51
Patient Safety Monitoring in International Laboratories (SMILE)

Exercise 3

52
Patient Safety Monitoring in International Laboratories (SMILE)

QC Example 1
• Know variation of mean 2 fl
• Initial MCV mean – 84 fl
• Historical 2 SD – +/- 4 fl
• Use half known variation accommodate change
 1 fl
• What should the mean be?
 85
• Established range – 81-89 fl
• Cumulative mean at end of product life should be 85.

53
Patient Safety Monitoring in International Laboratories (SMILE)

81 80 82 84 85 86 83 82 81 83 84 85 83 85 84 83 81 83 85 84 83 85 86 85 84 85 86 83 85 85 84 85 86 86 85 86 85 86 87 86 87 86 87 88 88 89 85 86 87 88 89 86 87 88 89 90 88 89 85.20

54
QC Example 2
• Manufacturer RBC mean – 2.29 x 106
• Manufacturer RBC Range – 2.18-2.40 x 106
• Calculated RBC mean – 2.35 x 106
• Is this mean valid?
• Our 2SD = 0.15 x 106
• Calculated RBC range – 2.20-2.50 x 106
• Yes mean within the expected range.

55
QC Example 3
• Manufacturer Platelet mean – 528 x 103
• Manufacturer Platelet Range – 407- 649x 103
• Calculated Platelet mean – 402x 103
• Is this mean valid?
• No below the expected range.

56
Commercial Control Monitoring

Levey-Jennings Charts

57
Patient Safety Monitoring in International Laboratories (SMILE)

Levey-Jennings QC Charts

58
Patient Safety Monitoring in International Laboratories (SMILE)

Trend

59
Patient Safety Monitoring in International Laboratories (SMILE)

Shift

60
Patient Safety Monitoring in International Laboratories (SMILE)

Bias

61
Patient Safety Monitoring in International Laboratories (SMILE)

62
Patient Safety Monitoring in International Laboratories (SMILE)

QC Policy

• Each laboratory should adopt QC rules.


• Establish policy/corrective action for
controls that are “Out”.
Documentation is important.
• Establish policy for Trends, bias and shifts.
• Establish when calibration are required.

63
Patient Safety Monitoring in International Laboratories (SMILE)

64
Patient Safety Monitoring in International Laboratories (SMILE)

65
Patient Safety Monitoring in International Laboratories (SMILE)

Policy Example
• If control out +/-2SD and a second Westgard rule is also
seen
 Rerun the control.
 If another vial of control is available use it.
 No more than 2 control reruns from same vial or new
vial should be made.
 If control still out begin troubleshooting do not report
patient results.
Check maintenance log
Check reagent
Check calibration date

66
Patient Safety Monitoring in International Laboratories (SMILE)

Troubleshooting Guideline
• Should have a policy on how to perform
trouble shooting for out of range results.
Instrument vs sample problem
Resolve problem before running patients
• Can create a checklist .
• Can also include a Corrective Action
Flowchart .

67
Patient Safety Monitoring in International Laboratories (SMILE)

Exercises 4

68
Patient Safety Monitoring in International Laboratories (SMILE)

LJ Example 1

69
Patient Safety Monitoring in International Laboratories (SMILE)

LJ Example 2

70
Patient Safety Monitoring in International Laboratories (SMILE)

LJ Example 3

71
Patient Safety Monitoring in International Laboratories (SMILE)

LJ Exercise 4

72
Patient Safety Monitoring in International Laboratories (SMILE)

LJ Example 5

73
Patient Safety Monitoring in International Laboratories (SMILE)

Internal Quality Control

Retained Patient Controls

74
Patient Safety Monitoring in International Laboratories (SMILE)

Retained Patient Control


• Two-three patient samples with specific
parameters.
• Can be used over a 24 hour period.
• Cost efficient.
• Can be used to detect systematic error.
• Transferable between instruments and
modes.

75
Sample Type WBC HGB
Control 1 5.0-10.0 x 103/mm3 12.0-15.0 mg/dL
Control 2 10.0-15.0 x103 /mm3 7.0-10.0 mg/dL

• Parameter Control 1 Control 2

WBC ± 0.6 ± 1.4


RBC ± 0.14 ± 0.14
HGB ± 0.3 ± 0.3
HCT ± 2.0 ± 2.0
MCV ± 2.0 ± 2.0
PLT ± 40.0 ± 40.0

• Just like commercial controls should have


policy for “Outliners and corrective action.
76
Control Decisions
If Patient Control outside of acceptable range rerun
• IF • THEN
– Acceptable – Proceed with patients
– Still out – Use back-up method
– Results still the same – Sample deterioration
on back-up instrument proceed with patients
– Results acceptable on – Indicate instrument
problem, use back-up
backup instrument
instrument.
– Inform QC tech or
supervisor

77
Patient Safety Monitoring in International Laboratories (SMILE)

Exercises 5

78
Patient Safety Monitoring in International Laboratories (SMILE)

Patient QC Example 1
Original Result Scheduled rerun
• WBC – 5.5 x 103 /ul • WBC- 5.9 x 103 /ul
• RBC – 3.554 x 106 /ul • RBC – 3.354 x 106 /ul
• Hgb – 12.4 g/dl • 12.0
• Hct – 36.5 % • 33.5 %
• MCV – 85 fl • 84 fl
• Plat – 250.0 x 103 /ul • 268.0 x 103 /ul

79
Patient Safety Monitoring in International Laboratories (SMILE)

Patient QC Example 1
Original Result Repeat Result
• WBC – 5.5 x 103 /ul • WBC- 5.8 x 103 /ul
• RBC – 3.554 x 106 /ul • RBC – 3.254 x 106 /ul
• Hgb – 12.4 g/dl • 12.0
• Hct – 36.5 % • 33.0 %
• MCV – 85 fl • 85 fl
• Plat – 250.0 x 103 /ul • 260.0 x 103 /ul

80
Patient Safety Monitoring in International Laboratories (SMILE)

Patient QC Example 1
Original Result Back-up Result
• WBC – 5.5 x 103 /ul • WBC- 5.8 x 103 /ul
• RBC – 3.554 x 106 /ul • RBC – 3.354 x 106 /ul
• Hgb – 12.4 g/dl • 12.1
• Hct – 36.5 % • 33.5 %
• MCV – 85 fl • 85 fl
• Plat – 250.0 x 103 /ul • 265.0 x 103 /ul

81
Patient Safety Monitoring in International Laboratories (SMILE)

Internal Quality Control

XB- Moving Average

82
Patient Safety Monitoring in International Laboratories (SMILE)

XB – Moving Averages
• Cost effective quality control method.
• Allows for continuous monitoring of system
performance.
• Uses patient samples in conjunction with
other controls.
• Created by Brian S Bull.
• Algorithm evaluates RBC indices.
• Must run either 100/day or 400/week

83
Patient Safety Monitoring in International Laboratories (SMILE)

How to Set Target Values


• Start with Bull’s values:
MCV = 89.5, MCH=30.5, MCHC=34.0
• Run 400 bloods or one week’s worth
• Calculate the mean (target value), SD and %CV
• %CV has to be </= 1.5%
• Target value should be within 3% of Bull’s
• The values must be physiologically possible
• Upper and lower range set at 5% of target

84
Patient Safety Monitoring in International Laboratories (SMILE)

Reason Why Moving Average


to be Out
• Non-random population

• Instrument problem

• Calibration

85
Patient Safety Monitoring in International Laboratories (SMILE)

Exercises 6

86
Patient Safety Monitoring in International Laboratories (SMILE)

Parameters used in XB
• MCV – usually direct measurement

• MCH = Hgb x 10/RBC

• MCHC = Hgb x 100 / HCT (Usually Calculate)


HCT = RBC x MCV/10

87
Patient Safety Monitoring in International Laboratories (SMILE)

How to troubleshoot with XB


• MCV
 Involves RBC aperture
 Tell if problem with sizing or flow problem
• MCH
 Involves Hemoglobin sample which is part of WBC
sample
 Involves RBC count
• MCHC
 Involves all three parameters.

88
Patient Safety Monitoring in International Laboratories (SMILE)

XB Troubleshooting Policy
• Moving Average Acceptability
If Then
Moving average parameters agree within the established Proceed with test of patient samples.
limits set
If 5-6 batches fall outside the limit set and cannot be Hold testing of patient samples and run on backup until
explained investigation complete

• Investigation

89
Patient Safety Monitoring in International Laboratories (SMILE)

Example 1

90
Patient Safety Monitoring in International Laboratories (SMILE)

MCV

MCH

MCHC

91
Yes Yes Yes

Yes
No
Yes Yes

No
No

92
Patient Safety Monitoring in International Laboratories (SMILE)

Indices Pattern: MCV MCH MCHC OK


• Make the aperture • Increase MCV
diameter smaller

• Decrease number • MCH = Hgb x 10/RBC


RBC getting through  Increase MCH
• MCHC = Hgb x 1000
RBC x MCV
 No change

93
Patient Safety Monitoring in International Laboratories (SMILE)

Example 2

94
Patient Safety Monitoring in International Laboratories (SMILE)

MCV

MCH

MCHC

95
Patient Safety Monitoring in International Laboratories (SMILE)

Yes
Hgb

RBC Yes
Yes

No No

Yes

96
Patient Safety Monitoring in International Laboratories (SMILE)

Indices Pattern: MCV OK MCH MCHC


• Bubbles in cuvette • MCH = Hgb x 10/RBC
Increase Blank  Decrease MCH
Reading • MCHC = Hgb x 1000
Decrease Hgb RBC x MCV
 Decrease MCHC
• MCV
 No change
• Possible H&H Check

97
Patient Safety Monitoring in International Laboratories (SMILE)

Indices Pattern: MCV OK MCH MCHC


• Low vacuum • MCH = Hgb x 10/RBC
increased  Decrease MCH
Increase RBC • MCHC = Hgb x 1000
RBC x MCV
 Decrease MCHC
• MCV
 No change
• Possible H&H Check

98
Patient Safety Monitoring in International Laboratories (SMILE)

Example 3

99
Patient Safety Monitoring in International Laboratories (SMILE)

MCV

MCH

MCHC

100
Patient Safety Monitoring in International Laboratories (SMILE)

Yes

Yes Yes

No No

101
Patient Safety Monitoring in International Laboratories (SMILE)

Indices Pattern: MCV MCH OK MCHC


• Frozen Diluent • MCV
Thawed will  Increased
separate into two • MCH = Hgb x
layers 10/RBC
Hypotonic on top
 No change
Hypertonic on
• MCHC = Hgb x 1000
bottom
When get to top RBC x MCV
layer cause RBC  Decrease MCHC
swell
102
Patient Safety Monitoring in International Laboratories (SMILE)

Correlation/Comparison

• Blood count to blood film

• Blood count changes to clinical events

• Instrument to instrument

103
Patient Safety Monitoring in International Laboratories (SMILE)

Factors to Consider with IQC


• Type of instrument – if fully automated.
• The size of the lab.
• The level of training of your staff.
• The number of specimens handled each
day.
• Dayshift vs 24 hour laboratory.
• Country’s own regulations.
• Accreditation requirements.
104
Patient Safety Monitoring in International Laboratories (SMILE)

IQC Recommendations
• A three level commercial control along with a
retained patient control.
• If patient numbers permits add XB to IQC
• Commercial controls
Two levels at beginning, middle and end of
shift
• Retained Patient Controls
At equal times between commercial controls

105
Patient Safety Monitoring in International Laboratories (SMILE)

QC Schedule Example

• 8:00 AM Commercial Controls level 1 and 2


10:30 AM Retained Patient Controls
• 1:00 PM Commercial controls Level 2 and 3
3:30 PM Retained Patient Controls
• 6:00 PM Commercial Controls Level 1 and 3

106
Patient Safety Monitoring in International Laboratories (SMILE)

107
Patient Safety Monitoring in International Laboratories (SMILE)

EXTERNAL QUALITY
CONTROL

108
Patient Safety Monitoring in International Laboratories (SMILE)

Why need EQA

• To detect errors not detectable by internal


controls.
• Ensures harmonization between
laboratories.
• Used recognize systematic errors.
Lab Result – Mean/SD = SDI

109
Patient Safety Monitoring in International Laboratories (SMILE)

• Bias –two or more specimen’s SDI are >


2.0
• Shifts –All specimen’s SDI in single event
> 1.0 on opposite side of previous event
• Trends – SDIs increase progressively in
one direction for three EQA events away
from mean

110
Patient Safety Monitoring in International Laboratories (SMILE)

SDI Interpretation

• <1.0 = satisfactory performance


• 1.0-2.0 = still acceptable but borderline
• 2.0-3.0 = requires review of techniques
and check on calibration
• >3.0 = defect requiring urgent investigation

111
Patient Safety Monitoring in International Laboratories (SMILE)

Exercises
7

112
Patient Safety Monitoring in International Laboratories (SMILE)

EQA Example 1
MCV

113
Patient Safety Monitoring in International Laboratories (SMILE)

EQA Example 2
Instrument Differential

114
Patient Safety Monitoring in International Laboratories (SMILE)

115
Patient Safety Monitoring in International Laboratories (SMILE)

 
INVESTIGATIVE ACTIONS AND ROOT CAUSE: Briefly discuss what actions were taken in this
investigation and what you believe is the possible cause.
1. We checked to find out whether there were clerical errors and found out that there was
none.
2. After replacing the flow cell, the EQA specimen which failed were re-run and all were
within range.
The cause of the EQA failure was a faulty flow cell in the CBC/Differential Analyzer.
This was confirmed because after replacing the flow cell the EQA samples were re-run, all
of the values that had previously failed now fell within acceptable limits of intended
results.

116
Patient Safety Monitoring in International Laboratories (SMILE)

EQA Example 3

117
Patient Safety Monitoring in International Laboratories (SMILE)

CV
is

118
Patient Safety Monitoring in International Laboratories (SMILE)

EQA Example 4
RBC Problem

119
Patient Safety Monitoring in International Laboratories (SMILE)

120
Patient Safety Monitoring in International Laboratories (SMILE)

EQA Example 5
Multiple Analyte Problems

121
Patient Safety Monitoring in International Laboratories (SMILE)

122
Patient Safety Monitoring in International Laboratories (SMILE)

123
Patient Safety Monitoring in International Laboratories (SMILE)

Summary and Conclusion


• Standardization
• Pre Analytic Control
• Post Analytic Control
• Analytical Control
Internal Quality Control
External Quality Assessment
124
Patient Safety Monitoring in International Laboratories (SMILE)

Questions and Answers?

125
Patient Safety Monitoring in International Laboratories (SMILE)

References
• Quality Control (QC) Information and Troubleshooting
Guide – Hematology – Beckman Coulter
• The use of retained patient specimens for hematology
quality control. Hackney JR, Cembrowski GS
• An optimized quality control procedure for hematology
analyzers with the use of retained patient specimens.
Cembrowski GS, Lunetzky ES, Patrick CC, Wilson MK
• Establishing Quality Control Means and Standard
Deviation for Hematology Instrument, Streck
• Quality Assurance in Hematology, WHO

126

You might also like